piperacillin has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cipelli, R; Dangoor, A; Hodgson, M; Lester, JF; Naik, J; Newsom-Davis, T; Patel, A; Shah, R; Summerhayes, M; Talbot, D; Talbot, T | 1 |
| Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W | 1 |
2 other study(ies) available for piperacillin and Lung Neoplasms
| Article | Year |
|---|---|
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Retrospective Studies; Sepsis; Taxoids; Tazobactam | 2017 |
Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumor.
Topics: Animals; Cefotaxime; Cell Line; Clindamycin; Cytotoxicity, Immunologic; Killer Cells, Natural; Lung Neoplasms; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin; Sarcoma, Experimental | 1984 |